INTERNATIONAL PATENT: ADARX PHARMACEUTICALS, INC. FILES APPLICATION FOR "COAGULATION FACTOR XI-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF"

GENEVA, Feb. 4 -- ADARX PHARMACEUTICALS, INC. (5871 Oberlin DriveSuite 200San Diego, CA 92121) filed a patent application (PCT/US2024/038771) for "COAGULATION FACTOR XI-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF" on Jul 19, 2024. With publication no. WO/2025/024283, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Zhen (c/o ADARx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), ZHU, Rui (c/o ADARx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), MACLEOD, Alan Robert...